No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full results3 funds hold a position and insiders have been net buying.
Buys (3)
Floyd Gregory Everette
$358K
private deal
Lucas James A Jr
$240K
private deal
Gussenhoven John Walter
$200K
private deal
Top-trader positions in FCBM could not be loaded.
Hyperliquid positioning - not every stock is covered
Last report
Aug 14, 2026
Period ending
Jun 30, 2026
Earnings per share
EPS comparison unavailable
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 14, 2026 | Unavailable | - | $32.3M No estimateSEC filing · Net interest plus noninterest income | Unavailable |
| Jun 30, 2025 | Aug 14, 2026 | Unavailable | - | $36.7M No estimateSEC filing · Net interest plus noninterest income | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
Reasonably priced and profitable.
Valuation
Quality
Growth
This stock is trending upward.
Trend
Constructive
75 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace